Stephanie Prince
Investor Relations, PCG Advisory
Replay available
Oncocyte Corporation (OCX) Q2 2023 Earnings Call
Oncocyte Corporation (NASDAQ: OCX) Q2 2023 earnings conference call, held 2023-08-10. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Josh Riggs
President and Chief Executive Officer, OncoSite
Nathan Merrico
Analyst, Stevens
Mike Madsen
Analyst, Needham & Co.
Unidentified Participant
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Insight Molecular Diagnostics Inc..
Replay transcript excerpt
WEBVTT 00:00:00.049 -- 00:00:01.770 Ladies and gentlemen, thank you for standing by. 00:00:01.770 -- 00:00:07.712 The conference will begin shortly. Please continue to hold and thank you for your patience. 00:01:01.018 -- 00:01:03.420 Thank you. 00:01:29.727 -- 00:01:32.008 And welcome to the OncoSite 00:01:32.008 -- 00:01:36.291 Q2 2023 earnings call. All participants will be in listen-only mode. 00:01:36.291 -- 00:01:39.633 Should you need assistance, please signal a conference specialist by pressing the star 00:01:39.633 -- 00:01:43.815 key followed by zero. After today's presentation, there will be an opportunity to ask 00:01:43.815 -- 00:01:48.477 questions. To ask a question, press star then one on your touchtone phone. 00:01:48.477 -- 00:01:51.879 To withdraw from the question queue, please press star then two. 00:01:51.879 -- 00:01:54.861 Please note this event is being recorded. 00:01:54.861 -- 00:01:59.144 I would now like to turn the conference over to Stephanie Prince from PCG Advisory. 00:01:59.144 -- 00:02:01.504 Please go ahead. 00:02:01.745 -- 00:02:06.288 Thank you, Anthony. And thank you to everyone for joining us for today's conference call 00:02:06.288 -- 00:02:09.929 to discuss Oncocytes second quarter 2023 00:02:09.929 -- 00:02:14.051 financial results and recent operating highlights. 00:02:14.051 -- 00:02:19.134 If you have not seen today's financial results press release, please visit the company's 00:02:19.134 -- 00:02:24.497 website on the investors page. Before turning the call over to Josh Riggs, 00:02:24.497 -- 00:02:29.349 Oncocytes president and chief executive officer I would like to remind you that during 00:02:29.349 -- 00:02:33.331 this conference call, the company will make projections and forward-looking statements 00:02:33.331 --...